Encompass Health Quarterly Income Statement
NYSE: EHCHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Encompass Health revenue and earnings
In the quarter ended Jun 30, 2026, Encompass Health generated $1.60 billion in revenue, up 9.6% from the same quarter a year earlier. Net income was $153.9 million (+8.3% year over year), for a net margin of 9.6% versus a median of 9.7% in the prior 5 quarters. Diluted earnings per share came in at $1.54, up from $1.39.
Summary generated from market data by MetaCap's automated system. Methodology
Encompass Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.60B | 1.59B | 1.54B | 1.48B | 1.46B | 1.46B | 1.41B | 1.35B | 1.30B | 1.32B | 1.25B | 1.21B |
| Revenue growth (YoY) | +9.58% | +9.01% | +9.94% | +9.36% | +12.03% | +10.59% | +12.69% | +11.94% | +9.61% | +13.41% | +9.63% | +10.78% |
| Interest Expense | 32.80M | 31.80M | 30.20M | 30.80M | 30.40M | 31.80M | 33.00M | 34.90M | 34.30M | 35.20M | 34.90M | 35.90M |
| Other Income (Expense) | 9.10M | 18.70M | 3.70M | 5.90M | 6.70M | 2.50M | 2.10M | 9.30M | 3.30M | 5.40M | 8.90M | 500.00K |
| Pretax Income | 261.60M | 288.70M | 257.70M | 219.90M | 236.80M | 238.60M | 201.40M | 183.80M | 186.00M | 178.40M | 164.80M | 145.00M |
| Income Tax | 53.60M | 56.40M | 55.40M | 44.90M | 51.00M | 41.60M | 37.60M | 36.00M | 38.30M | 38.30M | 37.20M | 30.30M |
| Net Income | 153.90M | 194.50M | 146.10M | 126.50M | 142.10M | 151.50M | 120.90M | 108.20M | 114.10M | 112.50M | 87.60M | 85.30M |
| Net Income growth (YoY) | +8.30% | +28.38% | +20.84% | +16.91% | +24.54% | +34.67% | +38.01% | +26.85% | +24.84% | +28.28% | -2.01% | +87.89% |
| EPS (Basic) | 1.55 | 1.96 | 1.45 | 1.26 | 1.41 | 1.50 | 1.20 | 1.08 | 1.13 | 1.12 | 0.87 | 0.85 |
| EPS (Diluted) | 1.54 | 1.93 | 1.43 | 1.24 | 1.39 | 1.48 | 1.18 | 1.06 | 1.12 | 1.10 | 0.86 | 0.84 |
| Shares Outstanding (Basic) | 98.80M | 99.20M | — | 100.50M | 100.60M | 100.50M | — | 99.90M | 99.90M | 99.80M | — | 99.50M |
| Shares Outstanding (Diluted) | 100.00M | 100.60M | — | 102.30M | 102.30M | 102.10M | — | 102.10M | 102.00M | 102.20M | — | 101.40M |
| Net Margin | 9.63% | 12.26% | 9.46% | 8.56% | 9.75% | 10.41% | 8.60% | 8.01% | 8.77% | 8.55% | 7.03% | 7.07% |
This table shows 12 quarterly periods of Encompass Health's income statement, from Q2 2026 back to Q3 2023, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow EHC's reporting calendar. What is a income statement?